Skip to content Carb-X
Carb-X
Boston University
Mobile Menu Toggle navigation
  • Sign Up
  • Contact
  • Twitter
  • LinkedIn
Carb-X
Boston University
Boston University
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Apply Here
    • Applicant Questions
  • Resources
    • CARB-X Connect
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
  • Events
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Apply Here
    • Applicant Questions
  • Resources
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
  • Events
  • Contact
  • Legal

Portfolio Company

  • Portfolio
  • >
  • Gallery
Pattern Bioscience Inc.

Pattern Bioscience Inc., Austin, TX, USA
https://www.pattern.bio

DX FOR RAPID ID/AST
SINGLE CELL BIOMETRIC ANALYSIS

Diagnostic
Pattern Bioscience (formerly Klaris Diagnostics) is developing a rapid identification and antimicrobial susceptibility test (ID/AST) to diagnose drug resistant infections quickly. Pattern’s technology combines single cell analysis with deep learning to deliver a fast and definitive diagnosis to guide antibiotic treatment decisions.  The approach involves the encapsulation of individual microbial cells into pico-scale droplets with a cell viability dye that concentrates within the droplet environment and produces an easily detectable fluorescent signal in the presence of a live cell.  Digital CultureTM technology enables phenotypic susceptibility testing across all common bacterial infections, thereby maximizing potential to improve antibiotic prescribing.

Current Development Stage: Development

CARB-X Investment: Initial investment of up to $6.8m with potential option payments up to $15.1m.

Initial CARB-X Investment Date: August 1, 2019

Read the Spotlight on Science about Pattern

Carb-X

Led by Boston University

Copyright 2023

  • Contact
  • Careers
  • Site Credits
  • Legal
  • Twitter
  • LinkedIn

Copyright 2023